New shot aims to restore skin color in vitiligo patients

NCT ID NCT06625177

Ongoing Disease control Sponsor: Teva Branded Pharmaceutical Products R&D LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new drug called TEV-53408 in 38 adults with vitiligo. The main goal is to see if the drug is safe when given as a shot under the skin. Researchers will also look for early signs that it might help bring back skin color. The study lasts 84 weeks, including treatment, a washout period, and follow-up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TEV-53408 injection
What this could lead to: If it works, this could point toward a new treatment option to help restore skin color in people with vitiligo.
What could go wrong: This is a very early, small Phase 1b trial focused on safety, not proof of effectiveness. The drug may not work or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VITILIGO

Contacts and locations

Locations

Teva Investigational Site 12043

Scottsdale, Arizona, 85260, United States
Teva Investigational Site 12044

Fremont, California, 94538, United States
Teva Investigational Site 12045

Dallas, Texas, 75230, United States
Teva Investigational Site 12046

Pasadena, California, 91101, United States
Teva Investigational Site 12047

Chicago, Illinois, 60614, United States
Teva Investigational Site 12048

Canton, Michigan, 48187, United States
Teva Investigational Site 12049

Miramar, Florida, 33025, United States
Teva Investigational Site 12051

Irvine, California, 92617, United States
Teva Investigational Site 12052

Hot Springs, Arkansas, 71913, United States
Teva Investigational Site 12053

Louisville, Kentucky, 40421, United States
Teva Investigational Site 12054

Portland, Oregon, 97210, United States
Teva Investigational Site 12055

South Jordan, Utah, 84095, United States
Teva Investigational Site 12057

Webster, Texas, 77598, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.